Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal
NEW YORK: Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal or more, the Wall Street Journal reported Thursday. While talks could fall apart, the companies are discussing a price near $200 per share and want to come to terms by Merck’s quarterly earnings call on July 28, according to the report. Seagen…